PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 4,955.00
-20.00 (-0.40%)
At close: Mar 9, 2026
PanGen Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 66,864 | 73,520 | 73,462 | 69,405 | 99,783 | 97,864 | Upgrade
|
| Market Cap Growth | -0.69% | 0.08% | 5.85% | -30.44% | 1.96% | 30.63% | Upgrade
|
| Enterprise Value | 54,554 | 69,814 | 74,767 | 67,446 | 92,638 | 96,121 | Upgrade
|
| Last Close Price | 4955.00 | 5700.00 | 6880.00 | 6500.00 | 9350.00 | 10150.00 | Upgrade
|
| PE Ratio | 39.09 | 77.91 | - | - | - | - | Upgrade
|
| Forward PE | - | 91.30 | 91.30 | 91.30 | 91.30 | 91.30 | Upgrade
|
| PS Ratio | 4.38 | 5.01 | 10.04 | 10.68 | 12.57 | 15.81 | Upgrade
|
| PB Ratio | 2.23 | 2.95 | 5.85 | 4.03 | 4.73 | 6.89 | Upgrade
|
| P/TBV Ratio | 2.30 | 3.05 | 6.29 | 4.10 | 4.80 | 7.02 | Upgrade
|
| P/FCF Ratio | - | 27.99 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 218.58 | 24.61 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 3.57 | 4.76 | 10.22 | 10.38 | 11.67 | 15.53 | Upgrade
|
| EV/EBITDA Ratio | 17.64 | 28.06 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 33.41 | 68.43 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -124.61 | 26.58 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.16 | 0 | 0.89 | 1.30 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.33 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | 0.31 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.43 | 0.14 | -0.05 | -0.26 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.98 | -4.26 | -0.69 | 0.28 | 3.08 | 0.14 | Upgrade
|
| Net Debt / FCF Ratio | 28.12 | -4.04 | -0.47 | 0.20 | 1.14 | 0.05 | Upgrade
|
| Asset Turnover | 0.53 | 0.57 | 0.35 | 0.20 | 0.20 | 0.16 | Upgrade
|
| Inventory Turnover | 1.46 | 1.48 | 0.94 | 1.07 | 1.82 | 2.12 | Upgrade
|
| Quick Ratio | 5.68 | 4.98 | 0.42 | 1.55 | 1.28 | 0.97 | Upgrade
|
| Current Ratio | 8.52 | 7.16 | 1.72 | 7.59 | 1.57 | 1.20 | Upgrade
|
| Return on Equity (ROE) | 6.83% | 5.04% | -30.14% | -23.46% | -18.75% | -26.69% | Upgrade
|
| Return on Assets (ROA) | 3.51% | 2.49% | -12.75% | -8.97% | -5.17% | -6.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.05% | 6.69% | -27.46% | -28.62% | -22.21% | -29.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.40% | 3.70% | -28.10% | -23.50% | -14.10% | -22.80% | Upgrade
|
| Earnings Yield | 2.45% | 1.28% | -6.11% | -6.48% | -3.32% | -4.45% | Upgrade
|
| FCF Yield | -0.65% | 3.57% | -5.27% | -6.10% | -4.76% | -5.56% | Upgrade
|
| Buyback Yield / Dilution | -16.88% | -7.03% | -0.13% | -4.47% | -6.02% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.